CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Biodesix, Inc. - BDSX CFD

1.7073
5.56%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.0254
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 1.6174
开盘价* 1.6273
1 年变化* -16.12%
日范围* 1.6273 - 1.7073
52 周范围 0.96-3.00
平均交易量(10 天) 173.65K
平均交易量(3 个月) 2.53M
市值 128.66M
市盈率 -100.00K
流通股 77.97M
收入 38.21M
EPS -1.60
股息(收益率 %) N/A
贝塔 -100.00K
下一个财报发布日期 May 9, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 24, 2023 1.7073 0.0800 4.92% 1.6273 1.7073 1.6273
Mar 23, 2023 1.6174 -0.2596 -13.83% 1.8770 1.8770 1.6074
Mar 22, 2023 1.8570 0.0799 4.50% 1.7771 1.8969 1.7472
Mar 21, 2023 1.7771 0.0300 1.72% 1.7471 1.7871 1.7372
Mar 20, 2023 1.7172 -0.0399 -2.27% 1.7571 1.7771 1.6173
Mar 17, 2023 1.7571 -0.0300 -1.68% 1.7871 1.8670 1.7472
Mar 16, 2023 1.7871 -0.0799 -4.28% 1.8670 1.9070 1.7172
Mar 15, 2023 1.8770 0.2896 18.24% 1.5874 1.8870 1.5874
Mar 14, 2023 1.6373 -0.0100 -0.61% 1.6473 1.6973 1.6274
Mar 13, 2023 1.6473 0.1498 10.00% 1.4975 1.7172 1.4975
Mar 10, 2023 1.5675 0.1398 9.79% 1.4277 1.6573 1.3877
Mar 9, 2023 1.4776 -0.2096 -12.42% 1.6872 1.6873 1.4676
Mar 8, 2023 1.6673 -0.0898 -5.11% 1.7571 1.7971 1.6673
Mar 7, 2023 1.7771 0.0599 3.49% 1.7172 1.7971 1.7172
Mar 6, 2023 1.7572 -0.3194 -15.38% 2.0766 2.1366 1.7172
Mar 3, 2023 1.9668 0.0000 0.00% 1.9668 2.0467 1.9668
Mar 2, 2023 1.9668 -0.0300 -1.50% 1.9968 2.0368 1.9569
Mar 1, 2023 1.9868 -0.0399 -1.97% 2.0267 2.0467 1.9369
Feb 28, 2023 2.0168 -0.0299 -1.46% 2.0467 2.1666 2.0068
Feb 27, 2023 2.0367 -0.1398 -6.42% 2.1765 2.2264 1.9568

Biodesix, Inc. Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018
总收入 54.506 45.557 24.552 20.432
收入 54.506 45.557 24.552 20.432
收入成本,共计 30.518 21.998 6.074 4.406
毛利 23.988 23.559 18.478 16.026
总营业费用 93.148 68.491 51.293 44.095
销售/一般/行政费用,总计 47.958 32.328 30.637 25.899
研究与开发 12.789 10.818 10.468 8.188
异常费用(收入) -0.676 0.818 4.114 5.602
营业收入 -38.642 -22.934 -26.741 -23.663
利息收入(费用),非经营净值 -4.508 -7.586 -2.953 -2.892
其他,净值 -0.009 -0.83 -1.032 0.389
税前净收入 -43.159 -31.35 -30.726 -26.166
税后净收入 -43.159 -31.35 -30.726 -26.166
未计算非常项目前的净收益 -43.159 -31.35 -30.726 -26.166
净收入 -43.159 -31.35 -30.726 -26.166
普通股股东可获收益 (不含非经常性项目) -43.159 -31.35 -30.726 -26.166
普通股股东可获收益 (含非經常性項目) -43.159 -31.35 -30.726 -26.166
摊薄净收入 -43.159 -31.35 -30.726 -26.166
摊薄后加权平均股 27.365 26.5615 26.2541 26.2541
扣除特别项目的每股摊薄盈利 -1.57716 -1.18028 -1.17033 -0.99665
Dividends per Share - Common Stock Primary Issue 0 0
每股正常摊薄盈利 -1.60186 -1.14948 -1.01363 -0.78327
Depreciation / Amortization 2.559 2.529
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 6.548 7.224 6.531 11.885 28.866
收入 6.548 7.224 6.531 11.885 28.866
收入成本,共计 3.235 2.493 2.722 7.085 18.218
毛利 3.313 4.731 3.809 4.8 10.648
总营业费用 21.009 19 16.499 22.472 35.177
销售/一般/行政费用,总计 14.487 13.558 13.607 11.425 11.927
研究与开发 3.206 2.852 3.293 3.323 3.321
异常费用(收入) 0.081 0.097 -3.123 0.639 1.711
营业收入 -14.461 -11.776 -9.968 -10.587 -6.311
利息收入(费用),非经营净值 -1.137 -1.496 -1.546 -0.815 -0.651
其他,净值 0.012 -0.01 0 0 0.001
税前净收入 -15.586 -13.282 -11.514 -11.402 -6.961
税后净收入 -15.586 -13.282 -11.514 -11.402 -6.961
未计算非常项目前的净收益 -15.586 -13.282 -11.514 -11.402 -6.961
净收入 -15.586 -13.282 -11.514 -11.402 -6.961
普通股股东可获收益 (不含非经常性项目) -15.586 -13.282 -11.514 -11.402 -6.961
普通股股东可获收益 (含非經常性項目) -15.586 -13.282 -11.514 -11.402 -6.961
摊薄净收入 -15.586 -13.282 -11.514 -11.402 -6.961
摊薄后加权平均股 31.07 27.059 28.051 27.73 26.604
扣除特别项目的每股摊薄盈利 -0.50164 -0.49085 -0.41047 -0.41118 -0.26165
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.49903 -0.48727 -0.5218 -0.38814 -0.19734
  • 年度
  • 每季度
2021 2020 2019 2018
流动资产总额 43.613 86.14 12.7 9.913
现金和短期投资 32.712 62.126 5.286 5.914
现金等价物 32.712 62.126 5.286 5.914
应收账款总额,净额 3.656 15.304 5.292 1.892
Accounts Receivable - Trade, Net 3.656 15.304 5.292 1.892
Other Current Assets, Total 7.245 8.71 2.122 2.107
Total Assets 76.097 121.07 41.633 39.057
Property/Plant/Equipment, Total - Net 4.179 3.178 2.12 1.388
Property/Plant/Equipment, Total - Gross 10.928 9.902 8.506 6.956
Accumulated Depreciation, Total -6.749 -6.724 -6.386 -5.568
Goodwill, Net 15.031 15.031 11.631 10.804
Intangibles, Net 11.617 13.26 15.092 16.852
Other Long Term Assets, Total 1.657 3.461 0.09 0.1
Total Current Liabilities 28.96 32.125 22.6 4.468
Accounts Payable 1.662 8.964 1.717 0.886
Accrued Expenses 4.899 4.69 1.899 1.568
Notes Payable/Short Term Debt 0 0 12.045 0
Other Current Liabilities, Total 22.38 6.631 6.939 2.014
Total Liabilities 56.37 79.904 76.213 53.125
Total Long Term Debt 9.993 15.926 23.812 23.099
Long Term Debt 9.993 15.926 23.812 23.099
Other Liabilities, Total 17.417 31.853 29.801 25.558
Total Equity 19.727 41.166 -34.58 -14.068
Redeemable Preferred Stock 0 0 193.959 183.962
Common Stock 0.031 0.027 0.001 0.001
Additional Paid-In Capital 321.669 299.953 2.324 2.107
Retained Earnings (Accumulated Deficit) -301.973 -258.814 -230.864 -200.138
Total Liabilities & Shareholders’ Equity 76.097 121.07 41.633 39.057
Total Common Shares Outstanding 30.7896 26.5615 26.2541 26.2541
Current Port. of LT Debt/Capital Leases 0.019 11.84 0
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 27.233 43.613 56.445 68.45 81.244
现金和短期投资 16.427 32.712 47.913 56.349 55.329
现金等价物 16.427 32.712 47.913 56.349 55.329
应收账款总额,净额 3.774 3.656 2.784 5.281 18.367
Accounts Receivable - Trade, Net 3.774 3.656 2.784 5.281 18.367
Other Current Assets, Total 7.032 7.245 5.748 6.82 7.548
Total Assets 61.651 76.097 89.997 101.804 115.486
Property/Plant/Equipment, Total - Net 6.247 4.179 4.432 3.378 3.387
Property/Plant/Equipment, Total - Gross 13.409 10.928 11.827 10.471 10.369
Accumulated Depreciation, Total -7.162 -6.749 -7.395 -7.093 -6.982
Goodwill, Net 15.031 15.031 15.031 15.031 15.031
Intangibles, Net 11.131 11.617 11.992 12.4 12.821
Other Long Term Assets, Total 2.009 1.657 2.097 2.545 3.003
Total Current Liabilities 29.811 28.96 22.787 21.272 16.124
Accounts Payable 2.12 1.662 1.6 1.16 3.747
Accrued Expenses 4.597 4.899 3.533 2.959 2.622
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.051 0.019 0.02 3.106 2.707
Other Current Liabilities, Total 23.043 22.38 17.634 14.047 7.048
Total Liabilities 53.87 56.37 73.964 76.031 79.054
Total Long Term Debt 10.055 9.993 29.975 29.955 30.328
Long Term Debt 10.055 9.993 29.975 29.955 30.328
Other Liabilities, Total 14.004 17.417 21.202 24.804 32.602
Total Equity 7.781 19.727 16.033 25.773 36.432
Redeemable Preferred Stock 0 0 0 0
Common Stock 0.032 0.031 0.027 0.027 0.027
Additional Paid-In Capital 325.308 321.669 304.697 302.923 302.18
Retained Earnings (Accumulated Deficit) -317.559 -301.973 -288.691 -277.177 -265.775
Total Liabilities & Shareholders’ Equity 61.651 76.097 89.997 101.804 115.486
Total Common Shares Outstanding 31.8893 30.7896 27.0201 26.9489 26.7854
  • 年度
  • 每季度
2021 2020 2019 2018
净收入/起跑线 -43.159 -31.35 -30.726 -26.166
经营活动产生的现金 -28.223 -21.366 -21.726 -17.677
经营活动产生的现金 3.178 2.903 2.793 1.74
非现金物品 7.167 11.882 7.852 6.496
营运资金的变化 4.591 -4.801 -1.645 0.253
投资活动产生的现金 -2.547 -2.927 -1.872 -0.617
资本支出 -2.547 -2.177 -1.416 -0.617
其他投资现金流量项目,总计 0 -0.75 -0.456 0
融资活动产生的现金 1.262 81.131 22.972 19.032
融资现金流项目 -0.5 -8.249 -0.119 -0.283
股票的发行(报废),净额 17.112 73.34 10.047 8.55
债务的发行(退还),净额 -15.35 16.04 13.044 10.765
现金净变化 -29.508 56.838 -0.626 0.738
已付现金利息 1.676 1.844
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -15.586 -43.159 -29.877 -18.363 -6.961
Cash From Operating Activities -13.099 -28.223 -18.026 -10.236 -11.326
Cash From Operating Activities 0.908 3.178 2.323 1.523 0.746
Non-Cash Items 2.674 7.167 4.704 5.336 3.721
Changes in Working Capital -1.095 4.591 4.824 1.268 -8.832
Cash From Investing Activities -0.352 -2.547 -1.906 -0.864 -0.516
Capital Expenditures -0.352 -2.547 -1.906 -0.864 -0.516
Other Investing Cash Flow Items, Total 0 0 0 0
Cash From Financing Activities -2.834 1.262 5.625 5.229 4.951
Financing Cash Flow Items -4.6 -0.5 0.232 -0.109 -0.108
Issuance (Retirement) of Stock, Net 1.674 17.112 0.739 0.679 0.475
Issuance (Retirement) of Debt, Net 0.092 -15.35 4.654 4.659 4.584
Net Change in Cash -16.285 -29.508 -14.307 -5.871 -6.891
Cash Interest Paid 0.223
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Schuler (Jack W) Individual Investor 25.5879 19952112 8695652 2022-11-21
Kennedy (Lawrence T Jr.) Individual Investor 19.0156 14827404 0 2023-01-03 MED
Patience (John) Individual Investor 9.0025 7019695 1739130 2022-11-21 LOW
Birchview Capital, LP Investment Advisor 6.4632 5039633 2884624 2022-12-31 LOW
AIGH Capital Management, LLC. Private Equity 5.8936 4595512 -973389 2022-12-31 MED
Cawthorn (Robert E) Individual Investor 4.6838 3652220 1723341 2022-11-21 LOW
Strobeck (Matthew W) Individual Investor 3.7251 2904668 1304345 2022-11-21 LOW
Industrial Development Funding LLC Corporation 2.432 1896374 0 2022-03-01 LOW
Worth Venture Partners, LLC Investment Advisor/Hedge Fund 1.9211 1497963 1497963 2022-12-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.4189 1106403 866747 2022-12-31 LOW
Wells Fargo Advisors Research Firm 0.9923 773725 5000 2022-12-31 LOW
Essex Investment Management Company, LLC Investment Advisor/Hedge Fund 0.4848 377994 -29 2022-12-31 LOW
Life Sciences Alternative Financing, L.L.C. Corporation 0.3771 294053 0 2022-03-01 LOW
Cannell & Co. Investment Advisor 0.2637 205605 0 2022-12-31 LOW
Hutton Scott Individual Investor 0.2561 199726 28499 2023-02-09 HIGH
Massarany (Hany) Individual Investor 0.1769 137934 130434 2022-11-21 HIGH
Hightower Advisors, LLC Investment Advisor 0.175 136434 136434 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.1617 126122 2052 2022-12-31 LOW
Endurant Capital Management LP Hedge Fund 0.1596 124430 -5706 2022-12-31 HIGH
Millennium Management LLC Hedge Fund 0.1382 107788 -10260 2022-12-31 HIGH

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Biodesix, Inc. Company profile

关于 Biodesix Inc.

Biodesix, Inc.是一家总部设在美国的公司,从事肿瘤学血液诊断测试的开发和商业化。 公司的产品Biodesix Lung Reflex整合了基因组学和蛋白质组学的血液结果,揭示了肺癌的两面性。 其GeneStrat测试为非小细胞肺癌(NSCLC)患者在72小时内提供基于血液的突变结果。 它的VeriStrat测试为估计肾小球滤过率(EGFR)突变(EGFR野生型)检测阴性或EGFR突变状态未知的(NSCLC)患者提供基于血液的预测性和预后性蛋白质组学信息。

Industry: Medical & Diagnostic Laboratories

Suite 100
2970 Wilderness Place
BOULDER
COLORADO 80301
US

收入报表

  • Annual
  • Quarterly

人们也观看

BTC/USD

27,492.65 Price
-0.540% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
多头隔夜费 -0.0194%
空头隔夜费 -0.0025%
隔夜费时间 21:00 (UTC)
价差 0.03

XRP/USD

0.45 Price
+5.120% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00345

Gold

1,978.85 Price
-0.760% 1D Chg, %
多头隔夜费 -0.0179%
空头隔夜费 0.0097%
隔夜费时间 21:00 (UTC)
价差 0.30

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易